{"id":"https://openalex.org/W2186270409","doi":null,"title":"Research Article FORMULATION AND DEVELOPMENT OF LORNOXICAM FAST DISSOLVING TABLETS: INFLUENCE OF DIFFERENT EXCIPIENTS ON PROPERTY AND PERFORMANCE OF PATIENT FRIENDLY DOSAGE FORM","display_name":"Research Article FORMULATION AND DEVELOPMENT OF LORNOXICAM FAST DISSOLVING TABLETS: INFLUENCE OF DIFFERENT EXCIPIENTS ON PROPERTY AND PERFORMANCE OF PATIENT FRIENDLY DOSAGE FORM","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2186270409","mag":"2186270409"},"language":"en","primary_location":{"id":"mag:2186270409","doi":null,"is_oa":false,"landing_page_url":"http://ijpcsonline.com/files/9.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027442832","display_name":"N. G. Raghavendra Rao","orcid":"https://orcid.org/0000-0002-2606-7962","observed_orcids":["https://orcid.org/0000-0002-2606-7962"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"N. G. Raghavendra Rao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2606-7962","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5027442832"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2189,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.45406789,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lornoxicam","display_name":"lornoxicam","score":0.9850000143051147},{"id":"https://openalex.org/keywords/fast-dissolving-tablets","display_name":"fast dissolving tablets","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.7350000143051147},{"id":"https://openalex.org/keywords/microcrystalline-cellulose","display_name":"microcrystalline cellulose","score":0.9390000104904175},{"id":"https://openalex.org/keywords/spray-dried-lactose","display_name":"spray-dried lactose","score":0.9549999833106995},{"id":"https://openalex.org/keywords/disintegration-time","display_name":"disintegration time","score":0.9440000057220459},{"id":"https://openalex.org/keywords/drug-release","display_name":"drug release","score":0.7929999828338623},{"id":"https://openalex.org/keywords/drug-excipient-compatibility","display_name":"drug-excipient compatibility","score":0.8799999952316284},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8169999718666077}],"concepts":[{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.7489181160926819},{"id":"https://openalex.org/C191168616","wikidata":"https://www.wikidata.org/wiki/Q5503337","display_name":"Friability","level":4,"score":0.7239056825637817},{"id":"https://openalex.org/C2779351475","wikidata":"https://www.wikidata.org/wiki/Q417374","display_name":"Microcrystalline cellulose","level":3,"score":0.7235546112060547},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.6702916026115417},{"id":"https://openalex.org/C2779040406","wikidata":"https://www.wikidata.org/wiki/Q2734874","display_name":"Lornoxicam","level":3,"score":0.6522946357727051},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5011017322540283},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.49473974108695984},{"id":"https://openalex.org/C2781218482","wikidata":"https://www.wikidata.org/wiki/Q724426","display_name":"Hydroxypropyl cellulose","level":3,"score":0.47951892018318176},{"id":"https://openalex.org/C2778139025","wikidata":"https://www.wikidata.org/wiki/Q408676","display_name":"Piroxicam","level":3,"score":0.4737858474254608},{"id":"https://openalex.org/C138651985","wikidata":"https://www.wikidata.org/wiki/Q186249","display_name":"Pharmaceutics","level":2,"score":0.4610520899295807},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.41570404171943665},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.4106346368789673},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3697354793548584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3527355194091797},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35018524527549744},{"id":"https://openalex.org/C2779251873","wikidata":"https://www.wikidata.org/wiki/Q80294","display_name":"Cellulose","level":2,"score":0.21900403499603271},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.18894726037979126},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.1770583987236023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1650141477584839},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14666301012039185},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.13470327854156494},{"id":"https://openalex.org/C201253974","wikidata":"https://www.wikidata.org/wiki/Q1330121","display_name":"First pass effect","level":3,"score":0.10508695244789124},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2186270409","doi":null,"is_oa":false,"landing_page_url":"http://ijpcsonline.com/files/9.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1555994455","https://openalex.org/W1566408227","https://openalex.org/W1983521939","https://openalex.org/W2047846970","https://openalex.org/W2075854967","https://openalex.org/W2146504168","https://openalex.org/W2159269801","https://openalex.org/W2189333728","https://openalex.org/W2313270758","https://openalex.org/W2334012401","https://openalex.org/W3041213290"],"related_works":["https://openalex.org/W3081437209","https://openalex.org/W3052426891","https://openalex.org/W3140058459","https://openalex.org/W4410939031","https://openalex.org/W6930586819","https://openalex.org/W2273482349","https://openalex.org/W7099231059","https://openalex.org/W2186498680","https://openalex.org/W2893852267","https://openalex.org/W7218117306"],"abstract_inverted_index":{"Lornoxicam":[0],"is":[1],"a":[2],"Non-steroidal":[3],"anti-inflammatory":[4],"drug":[5,75,110,128],"with":[6,112],"analgesic":[7],"properties":[8],"and":[9,48,57,74,108,118,121],"belongs":[10],"to":[11,88,98,104],"the":[12,16,21,63],"class":[13],"oxicams.":[14],"In":[15],"present":[17],"research":[18],"invention,":[19],"study":[20],"influence":[22],"of":[23,29,36,50,60],"various":[24],"excipients":[25,113,129],"on":[26],"disintegration":[27,72,85],"behavior":[28],"LOR.The":[30],"fast":[31],"dissolving":[32],"tablets":[33],"have":[34],"advantages":[35],"solid":[37],"dosage":[38],"forms":[39],"such":[40,53],"as":[41,54,102],"good":[42],"stability,":[43],"accurate":[44],"dosing,":[45],"easy":[46,55],"handling":[47],"those":[49],"liquid":[51],"formulations":[52,64],"administration":[56],"minimal":[58],"risk":[59],"suffocation.":[61],"All":[62],"were":[65,114,126],"evaluated":[66],"for":[67],"hardness,":[68],"friability,":[69],"wetting":[70],"time,":[71],"time":[73,86],"release":[76],"study.":[77],"Formulation":[78],"containing":[79],"microcrystalline":[80],"cellulose":[81],"(MCC)":[82],"shows":[83],"less":[84],"compared":[87,103],"others.":[89],"It":[90],"was":[91,96],"also":[92],"concluded":[93],"that":[94,124],"MCC":[95],"found":[97],"be":[99],"better":[100],"excipient":[101],"spray":[105],"dried":[106],"lactose":[107],"DC-Mannitol.The":[109],"compatibility":[111],"checked":[115],"by":[116],"FTIR":[117],"DSC":[119],"studies":[120],"results":[122],"reviles":[123],"there":[125],"no":[127],"interactions.":[130]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}